# VergeRx for Smokers Not Ready to Quit

> **NCT07693660** · NA · NOT_YET_RECRUITING · sponsor: **University of Virginia** · enrollment: 592 (estimated)

## Conditions studied

- Tobacco Use Cessation

## Interventions

- **BEHAVIORAL:** VergeRx
- **BEHAVIORAL:** SmokefreeTXT
- **DRUG:** NRT Lozenge (Combination)
- **DRUG:** Extended NRT Patch (16 weeks)
- **DRUG:** Standard NRT Patch (8 weeks)

## Key facts

- **NCT ID:** NCT07693660
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-12-01
- **Primary completion:** 2031-12-01
- **Final completion:** 2032-11-01
- **Target enrollment:** 592 (ESTIMATED)
- **Last updated:** 2026-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07693660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07693660, "VergeRx for Smokers Not Ready to Quit". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07693660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*